Last updated: July 10, 2026 · Reviewed using our Identify, Investigate, Inform, Improve framework · 8 min read
The question behind every “banned in Europe” headline
You’ve seen the claim: this ingredient is banned in Europe but still legal here. It shows up in comment sections, in “clean beauty” marketing, in the caption under a viral video. It’s meant to alarm you — and often it does.
But it skips a more useful question: who is actually checking, and what are they checking for?
Canada, the US, and the EU each have their own regulator, their own rulebook, and their own philosophy about what “safe enough to sell” means. None of them tests every product before it hits shelves. None of them is simply “stricter” or “safer” across the board. Understanding how each system actually works is the difference between reacting to a scary headline and knowing what it really means for what’s in your bathroom cabinet.
This is a companion piece to Hazard vs. Risk — read that one first if you haven’t, because the same logic applies here: a regulator restricting an ingredient tells you something was flagged, not that a product is dangerous.
The short version
| Canada (Health Canada) | United States (FDA) | European Union | |
|---|---|---|---|
| Pre-market approval? | No | No | No |
| What’s required before selling | Notification within 10 days of first sale | Facility registration + product listing | Notification via CPNP + a Cosmetic Product Safety Report |
| Ingredient control | Cosmetic Ingredient Hotlist (prohibited/restricted list, updated as evidence emerges) | No pre-set prohibited list; safety substantiation required by law since 2023 | Annex II — a standing list of 1,400+ prohibited substances |
| Approach | Risk-based, updated case by case | Historically hands-off; tightened significantly under MoCRA (2022) | Precautionary — ingredients can be pre-emptively restricted based on hazard classification alone |
None of these is a report card. They’re three different tools built around three different ideas of what regulation should do.
Canada: notification, not approval
Cosmetics sold in Canada fall under the Food and Drugs Act and the Cosmetic Regulations, administered by Health Canada. Here’s the part that surprises people: Health Canada does not review or approve a cosmetic before it goes on sale. Instead, the company selling it must submit a Cosmetic Notification Form within 10 days of the product’s first sale in Canada, declaring what’s in it.
The safety net is the Cosmetic Ingredient Hotlist — a living document that names ingredients that are prohibited outright or restricted to specific concentrations and uses. It isn’t law in itself; it’s Health Canada’s public statement of how it will interpret the general safety requirement in the Cosmetic Regulations. When new evidence comes in, the Hotlist gets amended. That’s exactly what’s happening right now: Health Canada has a consultation open on proposed additions and changes, and a separate rule taking effect through 2026 that will require certain fragrance allergens to be named on the label instead of hidden inside the word “fragrance.”
This is the same mechanism that flagged the comfrey-derived ingredients we covered in our ingredient hotlist piece — a restriction added because of emerging evidence, not a recall of everything already on shelves.
United States: a system that just changed
For decades, the FDA’s authority over cosmetics was strikingly limited — no mandatory registration, no required safety testing, no pre-market review. That changed with the Modernization of Cosmetics Regulation Act (MoCRA), signed into law in December 2022, with core provisions now in effect.
Under MoCRA, the company responsible for a cosmetic product now has to:
- Register its manufacturing facilities with the FDA and renew that registration every two years
- List each product it sells, including its ingredients, and update that listing annually
- Keep records substantiating that the product is safe for its intended use
- Report serious adverse events to the FDA within 15 business days
The FDA still doesn’t pre-approve individual products or maintain a banned-ingredients list the way Canada or the EU do. What changed is accountability: for the first time, there’s a paper trail and a legal obligation to be able to show your work if something goes wrong.
European Union: prevention over reaction
The EU works from the opposite direction. Under Regulation (EC) No 1223/2009, a “Responsible Person” must notify the product through the Cosmetic Products Notification Portal (CPNP) and hold a Cosmetic Product Safety Report before it can be sold — no government pre-approval, but a much heavier documentation burden up front.
The headline feature is Annex II, the EU’s standing list of prohibited substances, which now runs past 1,400 entries following a 2026 update (sometimes referred to as “Omnibus VIII”) that aligned the cosmetics rules with the EU’s broader hazard-classification system for chemicals. That link matters: under this system, an ingredient can be restricted because it’s classified as a carcinogen, mutagen, or reproductive toxin at a hazard level — regardless of the concentration actually used in a leave-on lotion or a rinse-off shampoo.
This is precisely the hazard-vs-risk distinction we keep coming back to. The EU’s approach is precautionary by design: classify the hazard, restrict the ingredient, and don’t wait for population-level harm data from cosmetic use specifically. It’s a defensible public health strategy — but it also means “banned in the EU” measures something different than “proven harmful at cosmetic-use levels.”
So which system is “best”?
Wrong question. They’re solving for different things.
Canada and the US lean toward evaluating real-world use and updating rules as evidence accumulates. The EU leans toward restricting based on an ingredient’s hazard classification, full stop. Neither approach is dishonest, and neither guarantees a product is unsafe or safe — a longer Annex II doesn’t mean Europeans are better protected any more than Health Canada’s notification-based system means Canadian products are an afterthought.
What actually tells you something useful: which specific ingredient is being discussed, at what concentration, in what type of product, and what the regulator’s own reasoning was. That’s the work we do in every review — the “Investigate” step in our Identify, Investigate, Inform, Improve method — instead of leaning on “banned somewhere” as a stand-in for “dangerous at any concentration in any format.”
Where This Actually Shows Up: Ingredient by Ingredient
Here’s the concrete version of the paragraph above — four real cases where Canada, the US, and the EU land in genuinely different places, as of 2026:
| Ingredient / Product | Canada | United States | European Union |
|---|---|---|---|
| Sunscreen UV filters | Hybrid system: mineral-only filters are Natural Health Products; chemical filters are non-prescription drugs. Roughly in between the other two on filter count. | Regulated as OTC drugs. Only 16 filters approved — FDA approved its first new filter in 25 years (bemotrizinol) in 2026. | Regulated as cosmetics, not drugs. 34 filters approved — more modern options than either Canada or the US. |
| Parabens | Hotlist-based review of individual parabens as safety data warrants. | No federal ban on any paraben used in cosmetics. | Five parabens banned outright since 2014 for insufficient safety data; four others allowed under concentration limits. |
| Hydroquinone (skin lightening) | Not yet banned; Health Canada has proposed prescription-only status. | OTC products removed from the market in 2020; prescription-strength still available. | Banned for cosmetic use. |
| PFAS (“forever chemicals”) | No nationwide cosmetic ban yet; Canada has signalled intent to regulate PFAS as a class. | No single federal ban — an expanding patchwork of state-level bans (Maine, Vermont, Minnesota, and others) instead. | No EU-wide cosmetic ban yet, though ECHA has moved toward a group-wide REACH restriction; France introduced its own national ban effective January 2026. |
Notice that no single system is the strictest across every row — the EU leads on parabens and hydroquinone, but Canada and the EU are actually closer to each other than to the US on sunscreen filter variety, for entirely different regulatory reasons. And PFAS shows that “regulated” doesn’t always mean one national rule — in the US right now, it means a patchwork of state laws more than a federal standard. See Hazard vs. Risk and Natural vs. Man-Made for why origin and geography alone never tell the whole story.
FAQ
Does Health Canada test cosmetics before they’re allowed to be sold?
No. Companies self-certify safety and notify Health Canada after the product is already on the market. Health Canada monitors compliance and can act after the fact, including through the Cosmetic Ingredient Hotlist.
Is the EU’s cosmetics regulation stricter than Canada’s or the US’s?
It depends what you mean by “stricter.” The EU prohibits more individual substances outright, but it does so using a hazard-based standard that doesn’t account for how a specific product is actually used. Canada and the US (post-MoCRA) put more weight on real-world risk assessment and documented safety substantiation.
Why does Canada allow an ingredient the EU has banned?
Usually because the two regulators are answering different questions — hazard classification versus risk at typical use levels — or because Health Canada hasn’t yet completed its own review of newer evidence. It’s rarely because Health Canada considered the same evidence and disagreed.
Has the US caught up to Canada and the EU on cosmetics regulation?
It’s closer than it was. MoCRA (2022) introduced facility registration, product listing, mandatory safety substantiation, and adverse event reporting for the first time. The US still doesn’t maintain a prohibited-ingredients list the way Canada and the EU do.
The Bottom Line
Health Canada, the FDA, and the EU each take a different approach to when and how ingredient safety gets evaluated — none of them is simply “stricter” or “safer” across the board, and the concrete examples above show why: the EU leads on parabens and hydroquinone, but Canada and the EU are actually closer to each other than to the US on sunscreen filter variety, for entirely different reasons. Knowing which system a claim is coming from, and what specific ingredient and concentration it’s actually about, turns a scary-sounding headline into something you can actually evaluate.
Stay curious, stay critical.
Georden
References
- Ecomundo. “Sunscreen UV Filters & SPF Testing: EU vs US vs Canada Comparison.”
- CNN. “FDA approves new sunscreen ingredient used for years in Europe and Asia.” (June 2026)
- Quality Smart Solutions. “Health Canada Revises the Sunscreen Monograph in Canada.”
- ScienceInsights. “Are Parabens Banned in Europe? What EU Law Says.”
- Health Canada. “Hydroquinone.”
- National Center for Biotechnology Information. “Prescription Ingredients in Skin-Lightening Products Found Over-the-Counter Post-Hydroquinone Ban.”
- Cosmeservice. “PFAS in Cosmetics: Upcoming Restrictions and Compliance Risks.”
- Z2Data. “Everything You Need to Know About PFAS in 2026.”
Author Bio
Georden Jones is the founder of The Peer Review. Read the full story.